반도체 다음 관심 가져야 할 섹터는?

Pull the Trigger for Profits💥Red Trigger💥 Guide on How to Participate for Free 📈 Go to Free Training Room: https://band.us/n/aba0b5ScGes5m 📈 Join Free Stock Consultation: 02-2128-8566 📌 Pull the Trigger for Profits💥Red Trigger💥 Make sure to take advantage of the stock analysis and blind recommended stocks! Stay tuned! ========================================= ■ Red Trigger (Mon–Fri, 23:00–24:00) ■ Trigger Agent: Han Boram ■ Trigger Hunter: Park Jeongsik ========================================== ■ Trigger Headlines ✔️ Pharmaceuticals and Biotech, Are They Finally Moving?... Semiconductor Supply and Demand Shifting to Biotech? ✔️ 'Robot Stocks' Left Alone After Jensen Huang's Departure... When Is the Buying Timing? ✔️ Quantum Computers, Pushed by Trump... What Is the Strategy to Secure Profits First? ■ Market Triggers ✔️ Biotech BioUSA Opens... Expectations for Strengthened Global Partnerships US Easing of Interchangeability Regulations... Expansion of K-Biosimilar Market Alteogen, Technology Export; Rokit Healthcare, NASDAQ Listing Imminent ✔️ Robotics ‘Focus on Mid-to-Long-Term Growth of Robotics Industry’… Inflow of Bargain Buying into Robot Stocks U.S. Department of Commerce to Implement Additional Regulations on Chinese Robots… Expectations of Indirect Benefits Government ‘Report on Robotics and AI Measures’… Full-scale Promotion of Robot Industry ✔️ Quantum Computers Trump Issues Executive Order to Deploy Quantum Computers by 2028 US-China Hegemony Race Enters All-Out Quantum Technology War Amazon to Launch Fully Commercial Quantum Computer Within 5 Years Xgate Successfully Switches Website to ‘Quantum-Resistant Cryptography’ ——————————————————————— ■ Stock Analysis (6/24) · Hyundai Glovis / 282,000 KRW / 29% · L&C Bio / 85,000 KRW / 15% · Korean Air / 29,000 KRW / 10% · Hyundai Mobis / 600,000 KRW / 7% · Keystron / 6,100 KRW / 30% ---------------------------------------- ✔️ Recommended Stock: Humedix (200670) Focusing on Hyaluronic Acid Fillers and Botulinum Toxin Sales... Account for 49% of total sales CMO business (prescription injectable drugs, arthritis treatments, etc.) accounts for over 40% Osteoarthritis injectable 'Hyhial Plus' successfully registered in Brazil One-third of Brazil's population aged 65 and older suffers from osteoarthritis... Potential for increased export sales Buy Price: 26,400 KRW or lower / Target Price: 31,000 KRW / Stop Loss Price: 24,500 KRW ✔️ Blind Recommended Stock: https://band.us/n/aba0b5ScGes5m Q1 2026 Sales 238.2 billion KRW · Operating Profit 1.8 billion KRW... Turned to profitability Subsidiary's ultra-small Micro LED technology... Entering the AI ​​data center optical communication market Entering the next-generation display market with Micro LED modules for AR glasses, etc. World's first 'HV opto-semiconductor' technology... Mass production begins with 4 top global automakers